MANNKIND CORPORATION

Other languages MannKind Corporation

Equities

MNKD

US56400P7069

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 12/02/2026 GMT			5-day change	1st Jan Change
5.630 ^USD	-1.92%		+2.18%	-0.71%

02-09	MannKind Enrolls First Patient in Study Evaluating Afrezza Inhaled Insulin in Youth	MT
02-09	MannKind announces first patient enrolled in Inhale-1st pediatric study evaluating Afrezza® for youth with newly-diagnosed type 1 diabetes (T1d)	RE

Other languages

18/10/21	MÄRKTE USA/Börse hakt schwache Daten ab - Technologiewerte gesucht
18/10/21	MÄRKTE USA/Erholt von Anfangsverlusten - Technologiewerte vorne
18/10/21	USA-Les valeurs à suivre à Wall Street (actualisé)
30/09/19	USA-Les valeurs à suivre à Wall Street (actualisé)

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

The best tools reserved for subscribers to boost the performance of your investments!